Pleiotropic activity of antihypertensives in atherothrombogenesis. Nebivolol: increasing possibilities and reducing restrictions

Pleiotropic activity of antihypertensives in atherothrombogenesis. Nebivolol: increasing possibilities and reducing restrictions

The review is devoted to the recent European recommendations' view on antihypertensive medications (AHM). The role of beta-adrenoblockers (BAB) in treating arterial hypertension (AH) patients is emphasized. Existing differences in pharmacological parameters and clinical effects are discussed fo...

ver descrição completa

Detalhes bibliográficos
Autor principal:	M. G. Bubnova
Formato:	Artigo
Idioma:	Russian
Publicado em:	«SILICEA-POLIGRAF» LLC 2008-12-01
coleção:	Кардиоваскулярная терапия и профилактика
Assuntos:	arterial hypertension beta-adrenoblockers pleiotropic effects atherothrombogenesis nebivolol
Acesso em linha:	https://cardiovascular.elpub.ru/jour/article/view/1641

Registros relacionados

URODYNAMIC EFFECTS OF BETA-ADRENOBLOCKERS: NEBIVOLOL ADVANTAGES
por: M. P. Savenkov, et al.
Publicado em: (2016-01-01)

THE PLACE OF NEBIVOLOL IN RATIONAL THERAPY OF CONGESTIVE HEART FAILURE
por: A. B. Khadzegova
Publicado em: (2014-09-01)

NEBIVOLOL: A THIRD GENERATION BETA BLOCKER AS ANTIHYPERTENSION AGENT
por: Ni Putu Wirantari, et al.
Publicado em: (2013-07-01)

Combination antihypertensive therapy in patients with arterial hypertension and coronary heart disease
por: T. E. Morozova, et al.
Publicado em: (2013-08-01)

Modern therapeutic potential of super-selective β<sup>1</sup>-adrenoblocker nebivolol
por: V. I. Makolkin, et al.
Publicado em: (1970-01-01)

Benefits of vasodilating beta-adrenoblockers for arterial hypertension treatment
por: V. B. Mychka
Publicado em: (2012-06-01)

Use of nebivolol in patients with idiopathic pulmonary hypertension: Results of the pilot study
por: T V Martyniuk, et al.
Publicado em: (2012-12-01)

Use of nebivolol in patients with mild and moderate hypertensive disease
por: L V Zhigunova, et al.
Publicado em: (2003-03-01)

Differential beta-adrenoblocker therapy in chronic heart failure
por: S. N. Tereshchenko, et al.
Publicado em: (1970-01-01)

NEBIVOLOL and the 2009 ESH update to the 2007 ESH/ESC Guidelines
por: V. I. Makolkin
Publicado em: (2010-12-01)

Microcirculation in arterial hypertension patients receiving beta-adrenoblockers
por: L. L. Kirichenko, et al.
Publicado em: (2006-12-01)

Endothelium dysfunction at arterial hypertension: focus on nebivolol
por: Nikolay Aleksandrovich Vaulin
Publicado em: (2009-03-01)

CHRONIC HEART FAILURE OF ISCHEMIC GENESIS AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: POSSIBILITIES OF COMBINATION THERAPY INCLUDING NEBIVOLOL
por: P. A. Fedotov, et al.
Publicado em: (2014-07-01)

CHRONIC HEART FAILURE OF ISCHEMIC GENESIS AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: POSSIBILITIES OF COMBINATION THERAPY INCLUDING NEBIVOLOL
por: P. A. Fedotov, et al.
Publicado em: (2014-07-01)

Effects of nebivolol on artery hypertension--multicentre study Bosnia and Herzegovina
por: Zumreta Kušljugić, et al.
Publicado em: (2005-02-01)

ARTERIAL HYPERTENSION IN PATIENTS WITH DIABETES MELLITUS: AN INDIVIDUALIZED CHOICE OF ANTIHYPERTENSIVE MEDICATIONS
por: T. E. Morozova, et al.
Publicado em: (2011-04-01)

Beneficial Effects of Nebivolol in Comparison with Atenolol on Safety and Tolerability in Essential Hypertension
por: Vivek V. Bhosale, et al.
Publicado em: (2014-06-01)

Nebivolol therapy and reduction of intravascular platelet activity in patients with atrial hypertension and metabolic syndrome
por: I. N. Medvedev
Publicado em: (2006-06-01)

RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY
por: M. L. Maximov
Publicado em: (2015-12-01)

Nebivolol for treatment patients with arterial hypertension
por: O M Mikheeva, et al.
Publicado em: (2014-09-01)

Modern management of arterial hypertension: has the position of beta-adrenoblockers changed
por: S. Yu. Martsevich
Publicado em: (2007-08-01)

Efficacy and safety of the first made in Russia alpha, beta long-acting adrenoblocker proxodolol in patients with arterial hypertension of the second degree
por: S A Belyaeva, et al.
Publicado em: (2011-04-01)

ANTIATHEROGENIC AND PLEIOTROPIC ACTIVITY OF VARIOUS DOSES OF ATORVASTATIN IN PATIENTS WITH ISCHEMIC STROKE
por: M. G. Bubnova, et al.
Publicado em: (2013-08-01)

Nebivolol And Quinapril Reduce P-Wave Duration And Dispersion In Hypertensive Patients
por: Hasan Korkmaz, et al.
Publicado em: (2009-05-01)

Effects of Nebivolol therapy on hemodynamic parameters and lipid profile compared to other beta blockers in patients with essential hypertension: a systematic review and meta-analysis
por: I Made Fermi Wikananda, et al.
Publicado em: (2024-01-01)

Efficacy and Safety of Nebivolol and Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Hyperlipidemia
por: Rhee MY, et al.
Publicado em: (2020-11-01)

AZILSARTAN AS A POTENT ANTIHYPERTENSIVE DRUG WITH POSSIBLE PLEIOTROPIC CARDIOMETABOLIC EFFECTS: A REVIEW STUDY.
por: Georgiopoulos Georgios, et al.
Publicado em: (2016-08-01)

Antiarrhythmic Properties of Beta Blockers: Focus on Nebivolol
por: Bülent Görenek, et al.
Publicado em: (2024-06-01)

HEMODYNAMIC AND METABOLIC EFFECTS OF NEBIVOLOL IN LOCOMOTIVE CREW STAFF WITH NEWLY DIAGNOSED ARTERIAL HYPERTENSION
por: I. V. Osipova, et al.
Publicado em: (2016-01-01)

EFFECT OF METOPROLOL ON COGNITIVE FUNCTION IN HYPERTENSIVE PATIENTS OF YOUNG TO MIDDLE AGE
por: S. A. Smakotina, et al.
Publicado em: (2016-01-01)

ONCE AGAIN ABOUT BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION. WHAT SHOULD DOCTOR RECOMMEND TO THE PATIENT?
por: S. Y. Martsevich
Publicado em: (2016-01-01)

Choosing therapeutic tactics in pregnant women with chronic arterial hypertension: the priorities
por: N. G. Pivonova, et al.
Publicado em: (2009-08-01)

DIURETIC-BASED COMBINATION THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION: RESULTS OF THE RUSSIAN TRUST STUDY
por: N. E. Gavrilova, et al.
Publicado em: (2013-08-01)

Data of Nebivolol on oxidative stress parameters in hypertensive patients
por: Helena C. Barroso, et al.
Publicado em: (2022-04-01)

Nebivolol-induced hepatoxicity: a case report
por: Lynn Srour, et al.
Publicado em: (2024-10-01)

Lichenoid type cutaneous hyperpigmentation induced by nebivolol
por: Abdullah Nabi Aslan, et al.
Publicado em: (2017-04-01)

Modern views on β-adrenoblocker therapy in elderly patients with chronic heart failure
por: E. V. Privalova
Publicado em: (2007-06-01)

IMPACT OF MODERN ANTIHYPERTENSION MEDICATIONS ON THE CENTRAL PRESSURE AND ARTERIAL RIGIDITY
por: L. I. Gusakovskaya, et al.
Publicado em: (2015-10-01)

Rational pharmacotherapy of chronic heart failure with increased endothelin-1 activity: beta-adrenoblocker nebivolol place
por: L. I. Olbinskaya, et al.
Publicado em: (2007-02-01)

THE PLACE FOR A NEW NATIONAL2MADE ΑΒ2BLOCKER, PROXODOLOL, IN THE TREATMENT OF HYPERTENSIVE CRISES
por: M. V. Leonova
Publicado em: (2002-10-01)